Key apoptotic genes APAF1 and CASP9 implicated in recurrent folate-resistant neural tube defects

Eur J Hum Genet. 2018 Mar;26(3):420-427. doi: 10.1038/s41431-017-0025-y. Epub 2018 Jan 22.

Abstract

Neural tube defects (NTDs) remain one of the most serious birth defects, and although genes in several pathways have been implicated as risk factors for neural tube defects via knockout mouse models, very few molecular causes in humans have been identified. Whole exome sequencing identified deleterious variants in key apoptotic genes in two families with recurrent neural tube defects. Functional studies in fibroblasts indicate that these variants are loss-of-function, as apoptosis is significantly reduced. This is the first report of variants in apoptotic genes contributing to neural tube defect risk in humans.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apoptosis
  • Apoptotic Protease-Activating Factor 1 / genetics*
  • Apoptotic Protease-Activating Factor 1 / metabolism
  • Caspase 9 / genetics*
  • Caspase 9 / metabolism
  • Cells, Cultured
  • Drug Resistance
  • Female
  • Fetal Death
  • Fibroblasts / metabolism
  • Fibroblasts / pathology
  • Folic Acid / administration & dosage
  • Folic Acid / therapeutic use
  • Humans
  • Loss of Function Mutation
  • Male
  • Neural Tube Defects / drug therapy
  • Neural Tube Defects / genetics*
  • Neural Tube Defects / pathology
  • Pregnancy

Substances

  • APAF1 protein, human
  • Apoptotic Protease-Activating Factor 1
  • Folic Acid
  • CASP9 protein, human
  • Caspase 9